Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
7 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to MediWound Ltd.’s names, not what it holds today.
Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
10
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'05'06'09'10'11'12'13'16'17'19'22'23'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
MEDIWOUND LTD. its own name
IL, as the owner printed on each patent
7 publishedMEDIWOUND LTD. its own name
named as the applicant on its applications, in IL
3 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Jul 12, 2022 | 11,382,958 | Debriding composition for treating wounds | Pharmaceuticals | MEDIWOUND LTD. |
| May 21, 2019 | 10,293,033 | Proteolytic extract from bromelain for the treatment of connective tissue disorders | Pharmaceuticals | MEDIWOUND LTD. |
| Dec 6, 2016 | 9,511,126 | Proteolytic extract from bromelain for the treatment of connective tissue disorders | Pharmaceuticals | MEDIWOUND LTD. |
| Sep 24, 2013 | 8,540,983 | Debriding composition from bromelain and methods of production thereof | Pharmaceuticals | MEDIWOUND LTD. |
| Feb 21, 2012 | 8,119,124 | Debriding composition from bromelain and methods of production thereof | Pharmaceuticals | MEDIWOUND LTD. |
| Sep 14, 2010 | 7,794,709 | Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome | Medical technology | MEDIWOUND LTD. |
| Oct 31, 2006 | 7,128,719 | System for enhanced chemical debridement | Medical technology | MEDIWOUND LTD. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 29, 2024 | 2024/0285735 | METHODS OF DEBRIDEMENT OF CHRONIC WOUNDS | Pharmaceuticals | MEDIWOUND LTD. |
| May 9, 2024 | 2024/0148842 | PROTEOLYTIC ENZYME MIXTURE FOR TREATING PSORIASIS | Pharmaceuticals | MEDIWOUND LTD. |
| Dec 28, 2023 | 2023/0414728 | METHODS OF TREATING SKIN CANCERS | Pharmaceuticals | MEDIWOUND LTD. |
| May 16, 2019 | 2019/0142910 | METHODS OF DEBRIDEMENT OF CHRONIC WOUNDS | Medical technology | MEDIWOUND LTD. |
| Jan 31, 2019 | 2019/0030140 | DEBRIDING COMPOSITION FOR TREATING WOUNDS | Pharmaceuticals | MEDIWOUND LTD. · patent 11,382,958 granted from it |
| Feb 23, 2017 | 2017/0049865 | PROTEOLYTIC EXTRACT FROM BROMELAIN FOR THE TREATMENT OF CONNECTIVE TISSUE DISORDERS | Pharmaceuticals | MEDIWOUND LTD. · patent 10,293,033 granted from it |
| Jul 5, 2012 | 2012/0171187 | DEBRIDING COMPOSITION FROM BROMELAIN AND METHODS OF PRODUCTION THEREOF | Pharmaceuticals | MEDIWOUND LTD. · patent 8,540,983 granted from it |
| Jun 9, 2011 | 2011/0134722 | Simultaneous Joint Inversion of Surface Wave and Refraction Data | Measurement | MEDIWOUND LTD. · patent 8,861,308 granted from it |
| Jan 8, 2009 | 2009/0010910 | COMPOSITIONS AND METHODS FOR DERMATOLOGICAL WOUND HEALING | Pharmaceuticals | MEDIWOUND LTD. |
| Sep 15, 2005 | 2005/0202071 | Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome | Medical technology | MEDIWOUND LTD. · patent 7,794,709 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.